Ultrasound Versus Fluoroscopy Guided Superior Hypogastric Plexus Block in Cancer Bladder Patients
Unknown statusNot applicableNCT05083702
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Pelvic cancer pain is a chronic condition related to the involvement of viscera, pelvic muscular structures or neural structures by tumor. The superior hypogastric plexus block is a sympathetic block used to treat pelvic visceral pain that is unresponsive to oral or parenteral opioids different approaches for superior hypogastric block as transdiscal approach, classic approach, Posteromedial approach, CT guided approach and ultrasound anterior approach The ultrasound-guided superior hypogastric plexus neurolysis technique (anterior approach) is simple to perform. We believe this block can be useful in cancer patients who are having difficulty in lying prone, because it is a procedure performed in the supine position and it is less time-consuming. It also avoids the radiation exposure involved with a computed tomography-guided and fluoroscopy posterior approach.
Study details
- Official title
- Ultrasound Versus Fluoroscopic Guided Superior Hypogastric Plexus Block in Cancer Bladder: A Randomized Controlled Trial
- Conditions
- Interventions
- Procedure: Fluoroscopy-guided superior hypogastric plexus block transdiscal approach
- Procedure: ultrasound-guided superior hypogastric plexus block
- Sponsor
- National Cancer Institute, Egypt
- Start date
- 2020-12-01
- Primary completion
- 2021-09-30
- Sex
- All
- Age range
- from 20 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age \> 20 years. * Patients with advanced stage cancer bladder. * Patient with severe pain (VAS) 7 or more . * Patients don't receive any strong opioids for pain at least 2 weeks Exclusion Criteria: * Patient refusal. * Local infection at the puncture site. * Coagulopathy. * Cognitive disorders. * Unstable cardiovascular disease. * History of psychiatric disorders. * History of drug abuse. * Patients allergic to medication used. * Patients with any contraindications to drugs and dye used.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05083702